Lexaria Bioscience Corp (LEXX)
3.13
+0.13
(+4.33%)
USD |
NASDAQ |
May 03, 16:00
3.11
-0.02
(-0.64%)
After-Hours: 20:00
Lexaria Bioscience Free Cash Flow: -5.408M for Feb. 29, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| February 29, 2024 | -5.408M |
| November 30, 2023 | -5.992M |
| August 31, 2023 | -6.051M |
| May 31, 2023 | -5.587M |
| February 28, 2023 | -5.065M |
| November 30, 2022 | -5.116M |
| August 31, 2022 | -5.06M |
| May 31, 2022 | -4.946M |
| February 28, 2022 | -4.876M |
| November 30, 2021 | -4.478M |
| August 31, 2021 | -4.069M |
| May 31, 2021 | -3.61M |
| February 28, 2021 | -3.067M |
| November 30, 2020 | -2.907M |
| August 31, 2020 | -2.652M |
| May 31, 2020 | -2.769M |
| February 29, 2020 | -3.425M |
| November 30, 2019 | -3.604M |
| August 31, 2019 | -3.775M |
| May 31, 2019 | -3.869M |
| February 28, 2019 | -3.115M |
| November 30, 2018 | -2.799M |
| August 31, 2018 | -2.603M |
| May 31, 2018 | -2.093M |
| February 28, 2018 | -2.110M |
| Date | Value |
|---|---|
| November 30, 2017 | -1.977M |
| August 31, 2017 | -1.556M |
| May 31, 2017 | -1.468M |
| February 28, 2017 | -0.9729M |
| November 30, 2016 | -0.5836M |
| August 31, 2016 | -0.681M |
| May 31, 2016 | -0.9924M |
| February 29, 2016 | -1.311M |
| November 30, 2015 | -1.577M |
| August 31, 2015 | -1.538M |
| May 31, 2015 | -1.184M |
| February 28, 2015 | -0.8853M |
| November 30, 2014 | -0.6413M |
| July 31, 2014 | -0.4211M |
| April 30, 2014 | -0.138M |
| January 31, 2014 | 0.0872M |
| October 31, 2013 | 0.2294M |
| July 31, 2013 | 0.3589M |
| April 30, 2013 | 0.1446M |
| January 31, 2013 | -0.0221M |
| October 31, 2012 | -0.1382M |
| July 31, 2012 | -0.7434M |
| April 30, 2012 | -0.6174M |
| January 31, 2012 | -0.6705M |
| October 31, 2011 | -0.8928M |
Free Cash Flow Range, Past 5 Years
-6.051M
Minimum
Aug 2023
-2.652M
Maximum
Aug 2020
-4.316M
Average
-4.274M
Median
Free Cash Flow Benchmarks
| Aurinia Pharmaceuticals Inc | -34.18M |
| Sunshine Biopharma Inc | -9.563M |
| Acasti Pharma Inc | -13.57M |
| Edesa Biotech Inc | -6.252M |
| Xenon Pharmaceuticals Inc | -150.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.6196M |
| Cash from Investing (Quarterly) | -0.057M |
| Cash from Financing (Quarterly) | 3.453M |
| Free Cash Flow Per Share (Quarterly) | -0.0629 |
| Free Cash Flow to Equity (Quarterly) | -0.6766M |
| Free Cash Flow Yield | -20.11% |